micro-community-banner
  • Saved

1yr
Albuminuria: An Underappreciated Risk Factor for Cardiovascular Disease - PubMed

Albuminuria: An Underappreciated Risk Factor for Cardiovascular Disease - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/38214258/

Albuminuria, an established biomarker of the progression of chronic kidney disease, is also recognized as a biomarker for the risk of cardiovascular disease. Elevated urinary albumin excretion indicates kidney damage...

Albuminuria is a key biomarker for chronic kidney disease progression and cardiovascular risk. Early detection and management can reduce cardiovascular complications, highlighting the importance of multidisciplinary surveillance and intervention.

  • Saved

1yr
Background Image DesktopBackground Image Mobile

This case series investigates the proportion of US counties and the overall population served by certified community behavioral health clinics (CCBHCs) from October 2016 to June 2024. CCBHCs play a vital role in enhancing behavioral health care quality and availability. The study examines the distribution and accessibility of these clinics, focusing on the impact of federal investments, including over $1.7 billion in expansion grants. Understanding the geographical spread of CCBHCs will shed light on whether their growth benefits specific areas or promotes equitable access nationwide, crucial for future policy decisions and funding strategies.

Read More

  • Saved

1yr
Background Image DesktopBackground Image Mobile

Healthcare systems globally face systemic inequities that affect marginalized groups. Digital health technologies (DHTs) have potential in addressing these disparities. The linked study aims to identify frameworks promoting health equity and assess DHTs' roles in implementing these guidelines. Additionally, it includes study analyses from multiple databases to guide future DHT development, ensuring equitable access and enhancing health equity.

Read More

  • Saved

1yr
Cholesterol-Lowering Strategies for Cardiovascular Disease Prevention: The Importance of Intensive Treatment and the Simplification of Medical Therapy - PubMed

Cholesterol-Lowering Strategies for Cardiovascular Disease Prevention: The Importance of Intensive Treatment and the Simplification of Medical Therapy - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/38610647/

Cardiovascular diseases (CVDs) are a leading global cause of mortality and are primarily driven by atherosclerotic coronary artery disease. Their pathogenesis involves multi-factorial mechanisms, among which low-density lipoprotein (LDL) plays...

Cardiovascular diseases are primarily driven by atherosclerosis, with LDL playing a key role. New guidelines advocate for intensive lipid-lowering therapies and PCSK9 inhibitors to improve outcomes and address adherence challenges.

  • Saved

1yr
Review of Evolocumab for the Reduction of LDL Cholesterol and Secondary Prevention of Atherosclerotic Cardiovascular Disease - PubMed

Review of Evolocumab for the Reduction of LDL Cholesterol and Secondary Prevention of Atherosclerotic Cardiovascular Disease - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/39076473/

Elevated low-density lipoprotein cholesterol (LDL-C) is a major causal factor for atherosclerotic cardiovascular disease (ASCVD), the leading cause of mortality worldwide. Statins are the recommended first-line lipid-lowering therapy (LLT) for...

Evolocumab significantly reduces LDL-C by over 60%, lowers cardiovascular events, and maintains safety in high-risk ASCVD patients, supporting early and aggressive LDL-C management for long-term benefits.